135 related articles for article (PubMed ID: 1681472)
1. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.
Tohgi H; Abe T; Hashiguchi K; Takahashi S; Nozaki Y; Kikuchi T
Neurosci Lett; 1991 May; 126(2):155-8. PubMed ID: 1681472
[TBL] [Abstract][Full Text] [Related]
2. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
Araki K; Takino T; Ida S; Kuriyama K
Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
[TBL] [Abstract][Full Text] [Related]
3. Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
Perschak H; Amsler U; Vischer A; Siegfried J; Cuénod M
Hum Neurobiol; 1987; 6(3):191-4. PubMed ID: 2896652
[TBL] [Abstract][Full Text] [Related]
4. Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; Navarro JA; Benito-León J; Ortí-Pareja M; Gasalla T; Cisneros E; Arenas J
J Neurol Sci; 1996 Sep; 141(1-2):39-44. PubMed ID: 8880690
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid corticotropin-releasing hormone in neurodegenerative diseases: reduction in spinocerebellar degeneration.
Suemaru S; Suemaru K; Kawai K; Miyata S; Nobukuni K; Ihara Y; Namba R; Urakami K; Hashimoto K
Life Sci; 1995; 57(24):2231-5. PubMed ID: 7475976
[TBL] [Abstract][Full Text] [Related]
6. Hair trace elements in cerebellar degeneration: low copper levels in late cortical cerebellar atrophy.
Oishi M; Takasu T; Tateno M; Uchida H
J Neurol; 1990 Jun; 237(3):163-5. PubMed ID: 2370563
[TBL] [Abstract][Full Text] [Related]
7. [Comparison between MRI and 3D-SSP in olivopontocerebellar atrophy and cortical cerebellar atrophy].
Hamaguchi H; Kanda F; Hosaka K; Fujii M; Chihara K
Rinsho Shinkeigaku; 2004; 44(4-5):263-7. PubMed ID: 15287507
[TBL] [Abstract][Full Text] [Related]
8. [GABA, glutamate, aspartate, glycine, and taurine contents in spinocerebellar degeneration and parkinsonism].
Tanaka Y; Mizuno Y
Rinsho Shinkeigaku; 1984 Mar; 24(3):256-63. PubMed ID: 6147219
[No Abstract] [Full Text] [Related]
9. [The cerebellar cortical atrophy syndrome].
Ponomareva EN; Astapenko AV; Likhachev SA; Ovsiankina GI; Pashko GV; Antonenko AI
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(9):14-9. PubMed ID: 9410595
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacological manipulation on neurotransmitter and other amino acid levels in the CSF of the Senegalese baboon Papio papio.
Valin A; Voltz C; Naquet R; Lloyd KG
Brain Res; 1991 Jan; 538(1):15-23. PubMed ID: 1673360
[TBL] [Abstract][Full Text] [Related]
11. Two types of quisqualate receptors are decreased in human olivopontocerebellar atrophy cerebellar cortex.
Makowiec RL; Albin RL; Cha JH; Young AB; Gilman S
Brain Res; 1990 Jul; 523(2):309-12. PubMed ID: 1976026
[TBL] [Abstract][Full Text] [Related]
12. Thiamine status in inherited degenerative ataxias.
Pedraza OL; Botez MI
J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):136-7. PubMed ID: 1538220
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
Burn DJ; Sawle GV; Brooks DJ
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
[TBL] [Abstract][Full Text] [Related]
14. Studies on neurotransmitter markers and neuronal cell density in the cerebellar system in olivopontocerebellar atrophy and cortical cerebellar atrophy.
Kanazawa I; Kwak S; Sasaki H; Mizusawa H; Muramoto O; Yoshizawa K; Nukina N; Kitamura K; Kurisaki H; Sugita K
J Neurol Sci; 1985 Dec; 71(2-3):193-208. PubMed ID: 2868072
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte glutamate dehydrogenase and CSF amino acids in late onset ataxias.
Kaakkola S; Marnela KM; Oja SS; Icén A; Palo J
Acta Neurol Scand; 1990 Oct; 82(4):225-9. PubMed ID: 2270751
[TBL] [Abstract][Full Text] [Related]
16. Glutamate and GABA levels in CSF from patients affected by dementia and olivo-ponto-cerebellar atrophy.
Tosca P; Canevari L; Di Paolo E; Ferrari R; Verzé S; Zerbi F; Dagani F
Acta Neurol Scand; 1992 Jun; 85(6):430-5. PubMed ID: 1353649
[TBL] [Abstract][Full Text] [Related]
17. Brain amino acid reductions in one family with chromosome 6p-linked dominantly inherited olivopontocerebellar atrophy.
Kish SJ; Robitaille Y; el-Awar M; Gilbert J; Deck J; Chang LJ; Schut L
Ann Neurol; 1991 Dec; 30(6):780-4. PubMed ID: 1686387
[TBL] [Abstract][Full Text] [Related]
18. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.
Polinsky RJ; Brown RT; Burns RS; Harvey-White J; Kopin IJ
J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):914-9. PubMed ID: 2462617
[TBL] [Abstract][Full Text] [Related]
19. [Amino acid metabolism in neurodegenerative diseases].
Nakamura S
Nihon Rinsho; 1992 Jul; 50(7):1637-42. PubMed ID: 1357203
[TBL] [Abstract][Full Text] [Related]
20. [Cerebrospinal fluid methoxyhydroxy-phenylene glycol in Parkinson's disease and spinocerebellar degeneration (author's transl)].
Mizuno Y
No To Shinkei; 1979 Mar; 31(3):309-12. PubMed ID: 444338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
